2-[(S)-butylsulfinyl]-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-[(R)-butylsulfinyl]-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-butylsulfinyl-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyrimidin-5-ylthieno[2,3-b]pyridin-3-amine;2-[(S)-3-methoxypropylsulfinyl]-4-(3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-[(R)-3-methoxypropylsulfinyl]-4-(3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine
C108H116N26O7S10 — CID 157049417
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(S)-butylsulfinyl]-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-[(R)-butylsulfinyl]-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-butylsulfinyl-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyrimidin-5-ylthieno[2,3-b]pyridin-3-amine;2-[(S)-3-methoxypropylsulfinyl]-4-(3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-[(R)-3-methoxypropylsulfinyl]-4-(3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine
2-[(S)-butylsulfinyl]-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-[(R)-butylsulfinyl]-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-butylsulfinyl-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyrimidin-5-ylthieno[2,3-b]pyridin-3-amine;2-[(S)-3-methoxypropylsulfinyl]-4-(3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-[(R)-3-methoxypropylsulfinyl]-4-(3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine (PubChem CID 157049417) has the molecular formula C108H116N26O7S10 and a molecular weight of 2210.96 g/mol. Its IUPAC name is 2-[(S)-butylsulfinyl]-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-[(R)-butylsulfinyl]-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-butylsulfinyl-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyrimidin-5-ylthieno[2,3-b]pyridin-3-amine;2-[(S)-3-methoxypropylsulfinyl]-4-(3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-[(R)-3-methoxypropylsulfinyl]-4-(3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine.
Molecular Properties
| Compound Name | 2-[(S)-butylsulfinyl]-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-[(R)-butylsulfinyl]-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-butylsulfinyl-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyrimidin-5-ylthieno[2,3-b]pyridin-3-amine;2-[(S)-3-methoxypropylsulfinyl]-4-(3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-[(R)-3-methoxypropylsulfinyl]-4-(3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine |
|---|---|
| PubChem CID | 157049417 |
| Molecular Formula | C108H116N26O7S10 |
| Molecular Weight | 2210.96 g/mol |
| Exact Mass | 2208.67 |
| IUPAC Name | 2-[(S)-butylsulfinyl]-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-[(R)-butylsulfinyl]-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-butylsulfinyl-4-(2-cyclopropyl-3-methylimidazol-4-yl)-6-pyrimidin-5-ylthieno[2,3-b]pyridin-3-amine;2-[(S)-3-methoxypropylsulfinyl]-4-(3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine;2-[(R)-3-methoxypropylsulfinyl]-4-(3-methylimidazol-4-yl)-6-pyridin-3-ylthieno[2,3-b]pyridin-3-amine |
| SMILES | CCCCS(=O)c1sc2nc(-c3cncnc3)cc(-c3cnc(C4CC4)n3C)c2c1N.CCCC[S@@](=O)c1sc2nc(-c3cccnc3)cc(-c3cnc(C4CC4)n3C)c2c1N.CCCC[S@](=O)c1sc2nc(-c3cccnc3)cc(-c3cnc(C4CC4)n3C)c2c1N.COCCC[S@@](=O)c1sc2nc(-c3cccnc3)cc(-c3cncn3C)c2c1N.COCCC[S@](=O)c1sc2nc(-c3cccnc3)cc(-c3cncn3C)c2c1N |
| InChI | InChI=1S/2C23H25N5OS2.C22H24N6OS2.2C20H21N5O2S2/c2*1-3-4-10-31(29)23-20(24)19-16(18-13-26-21(28(18)2)14-7-8-14)11-17(27-22(19)30-23)15-6-5-9-25-12-15;1-3-4-7-31(29)22-19(23)18-15(17-11-26-20(28(17)2)13-5-6-13)8-16(27-21(18)30-22)14-9-24-12-25-10-14;2*1-25-12-23-11-16(25)14-9-15(13-5-3-6-22-10-13)24-19-17(14)18(21)20(28-19)29(26)8-4-7-27-2/h2*5-6,9,11-14H,3-4,7-8,10,24H2,1-2H3;8-13H,3-7,23H2,1-2H3;2*3,5-6,9-12H,4,7-8,21H2,1-2H3/t2*31-;;2*29-/m10.10/s1 |
| InChIKey | AAAGWVHYZQUHTR-VYUNFTNFSA-N |
| XLogP | 21.74 |
| TPSA | 464.80 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 151 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2210.96 |
| LogP ≤ 5 | 21.74 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 38 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157049417 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.